Pharmaceutical spending Japan FY 2018-2024
the coronavirus disease (COVID-19), it was estimated to reach around 10.92 trillion yen. The spending in fiscal 2020 was forecasted to drop to around 10.73 trillion yen due to the impact of COVID-19. According to the source, the major factor impacting the pharmaceutical spend would be a decrease in non-COVID-19-related patient visits and doctor consultations.
In Japan, the total pharmaceutical spend was estimated to amount to approximately 10.94 trillion Japanese yen in fiscal year 2019. When including the impact of